In patients indicated for statin therapy who were recently nonadherent, a digital outreach strategy improved refill rates ...

More than 100,000 people are awaiting an organ transplant in the United States, with a new candidate added to the list every 10 minutes. Even if the transplant is carried out successfully, recipients ...

Clinical Question: Does personalized resuscitation improve outcomes in early septic shock when targeting capillary refill compared to usual care? Background: Resuscitation in early septic shock is ...

Ischemic colitis remains a diagnostic challenge, as endoscopic grading of mucosal ischemia is subjective and insensitive for transmural infarction. While the majority of non-gangrenous cases are ...

and serves as an important sign to detect conditions such as these. To give you the answer first, a healthy dog's gums are pink, and it is normal for them to return to pink within "1 to 2 seconds" ...

As part of the transaction, a “specialised” team within SessionM will join Capillary to ensure continuity and “preservation” of expertise Capillary Technologies said that the planned acquisition is ...

GREENVILLE, S.C. (FOX Carolina) - The South Carolina Department of Public Health announced Saturday that it has authorized a one-time early refill of Schedule III-V prescriptions due to the winter ...

Compared with standard care, personalized hemodynamic resuscitation targeting capillary refill time led to improved composite outcomes. A personalized hemodynamic resuscitation strategy targeting ...

Capillary Technologies, a global leader in AI-powered loyalty and customer engagement, today announced it has integrated with Adobe Experience Platform as a loyalty platform partner, setting a new ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

A personalized strategy aimed at normalizing capillary refill time (CRT) after early septic shock is better than usual care, results from the ANDROMEDA-SHOCK-2 trial have revealed. The findings are ...